Individual bioequivalence: New concepts in the statistical assessment of bioequivalence metrics

Clinical Pharmacokinetics

Volumn 33, Issue 1, 1997, Pages 1-6

  Patnaik, R N ^a   Lesko, L J ^a   Chen, M L ^a   Williams, R L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

BIOAVAILABILITY; BIOEQUIVALENCE; FOOD AND DRUG ADMINISTRATION; NOMENCLATURE; POPULATION; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

EID: 0030771117     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199733010-00001     Document Type: Review

References (23)

1. 1. S Anderson WW Hauck 1990 Consideration of individual bioequivalence J Pharmacokinet Biopharm 18 259 73 2380920 1:STN:280:DyaK3czjvFekuw%3D%3D Anderson S, Hauck WW. Consideration of individual bioequivalence. J Pharmacokinet Biopharm 1990; 18: 259–73
2. 2. S Anderson 1993 Individual bioequivalence: a problem of switch-ability [with discussion] Biopharm Reports 2 2 1 11 Anderson S. Individual bioequivalence: a problem of switch-ability [with discussion]. Biopharm Reports 1993; 2(2): 1–11
3. 3. WW Hauck S Anderson 1992 Types of bioequivalence and related statistical considerations Int J Clin Pharmacol Ther Toxicol 30 181 7 1592546 1:STN:280:DyaK383nsFyksA%3D%3D Hauck WW, Anderson S. Types of bioequivalence and related statistical considerations. Int J Clin Pharmacol Ther Toxicol 1992; 30: 181–7
4. 4. WW Hauck S Anderson 1994 Measuring switchability and prescribability: when is average bioequivalence sufficient? J Pharmacokinet Biopharm 22 551 64 7473081 1:CAS:528:DyaK2MXnsV2is7w%3D Hauck WW, Anderson S. Measuring switchability and prescribability: when is average bioequivalence sufficient? J Pharmacokinet Biopharm 1994; 22: 551–64
5. 5. G Ekbohm H Melander 1989 The subject-by-formulation interaction as a criterion for interchangeability of drugs Biometrics 45 1249 54 10.2307/2531776 Ekbohm G, Melander H. The subject-by-formulation interaction as a criterion for interchangeability of drugs. Biometrics 1989; 45: 1249–54
6. 6. Ekbohm G, Melander H. On variation, bioequivalence and interchangeability. Report 14. Uppsala: Department of Statistics, Swedish University of Agricultural Sciences, 1990
7. 7. S Hwang PB Huber M Hesney 1978 Bioequivalence and interchangeability J Pharm Sci 67 IV 660445 10.1002/jps.2600670603 1:STN:280:DyaE1c7ps1GhsQ%3D%3D Hwang S, Huber PB, Hesney M, et al. Bioequivalence and interchangeability. J Pharm Sci 1978; 67: IV
8. 8. VM Chinchilli 1996 The assessment of individual and population bioequivalence J Pharmacokinet Biopharm 6 1 14 1:STN:280:DyaK28vjsFyruw%3D%3D Chinchilli VM. The assessment of individual and population bioequivalence. J Pharmacokinet Biopharm 1996; 6: 1–14
9. 9. L Endrenyi M Schulz 1993 Individual variation and the acceptance of average bioequivalence Drug Inf J 27 195 201 10.1177/009286159302700135 Endrenyi L, Schulz M. Individual variation and the acceptance of average bioequivalence. Drug Inf J 1993; 27: 195–201
10. 10. L Endrenyi 1993 A procedure for the assessment of individual bioequivalence HH Blume KK Midha Bio-international: bioavailability, bioequivalence and pharmacokinetics Medpharm Publications Stuttgart 141 6 Endrenyi L. A procedure for the assessment of individual bioequivalence. In: Blume HH, Midha KK, editors. Bio-international: bioavailability, bioequivalence and pharmacokinetics. Stuttgart: Medpharm Publications, 1993; 141–6
11. 11. L Endrenyi 1994 A method for the evaluation of individual bioequivalence Int J Clin Pharm Ther Toxicol 32 497 508 1:STN:280:DyaK2M7itVagtg%3D%3D Endrenyi L. A method for the evaluation of individual bioequivalence. Int J Clin Pharm Ther Toxicol 1994; 32: 497–508
12. 12. L Endrenyi 1995 A simple approach for the evaluation of individual bioequivalence Drug Inf J 29 847 55 10.1177/009286159502900307 Endrenyi L. A simple approach for the evaluation of individual bioequivalence. Drug Inf J 1995; 29: 847–55
13. 13. JD Esinhart VM Chinchilli 1994 Sample size considerations for assessing individual bioequivalence based on the method of tolerance interval Int J Clin Pharmacol Ther 32 1 26 32 8199749 1:STN:280:DyaK2c3lvVeksA%3D%3D Esinhart JD, Chinchilli VM. Sample size considerations for assessing individual bioequivalence based on the method of tolerance interval. Int J Clin Pharmacol Ther 1994; 32(1): 26–32
14. 14. JD Esinhart VM Chinchilli 1994 Extension to the use of tolerance intervals for the assessment of individual bioequivalence J Biopharm Stat 4 1 39 52 8019583 10.1080/10543409408835071 1:STN:280:DyaK2c3ptVGhtQ%3D%3D Esinhart JD, Chinchilli VM. Extension to the use of tolerance intervals for the assessment of individual bioequivalence. J Biopharm Stat 1994; 4(1): 39–52
15. 15. DJ Holder F Hsuan 1993 Moment-based criteria for determining bioequivalence Biometrika 80 835 46 10.1093/biomet/80.4.835 Holder DJ, Hsuan F. Moment-based criteria for determining bioequivalence. Biometrika 1993; 80: 835–46
16. 16. R Schall HG Luus 1993 On population and individual bioequivalence Stat Med 12 1109 24 8210816 10.1002/sim.4780121202 1:STN:280:DyaK2c%2FitlGltA%3D%3D Schall R, Luus HG. On population and individual bioequivalence. Stat Med 1993; 12: 1109–24
17. 17. R Schall 1995 A unified view of individual, population and average bioequivalence HH Blume KK Midha Bio-international 2 Medpharm Scientific Publishers Stuttgart 91 105 Schall R. A unified view of individual, population and average bioequivalence. In: Blume HH, Midha KK, editors. Bio-international 2. Stuttgart: Medpharm Scientific Publishers, 1995; 91–105
18. 18. R Schall 1995 Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar Biometrics 51 615 26 7662849 10.2307/2532949 1:STN:280:DyaK2MzptFymsA%3D%3D Schall R. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar. Biometrics 1995; 51: 615–26
19. 19. LB Sheiner 1992 Bioequivalence revisited Stat Med 11 1777 88 1485060 10.1002/sim.4780111311 1:STN:280:DyaK3s7jsVagsg%3D%3D Sheiner LB. Bioequivalence revisited. Stat Med 1992; 11: 1777–88
20. 20. DJ Holder F Hsuan 1995 A moment-based method for determining individual bioequivalence Drug Inf J 29 965 79 10.1177/009286159502900318 Holder DJ, Hsuan F. A moment-based method for determining individual bioequivalence. Drug Inf J 1995; 29: 965–79
21. 21. S Anderson 1995 Current issues of individual bioequivalence Drug Inf J 29 961 4 10.1177/009286159502900317 Anderson S. Current issues of individual bioequivalence. Drug Inf J 1995; 29: 961–4
22. 22. Hauck WW, Chen ML, Hyslop T, et al., for the Individual Bioequivalence Working Group. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. Int J Clin Pharmacol Ther. In press
23. 23. DJ Schuirmann 1987 A comparison of the two one-sided tests procedure and the power approach for assessing the bioequivalence of average bioavailability J Pharmacokinet Biopharm 15 657 80 3450848 1:STN:280:DyaL1c3jtVajtQ%3D%3D Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the bioequivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15: 657–80